Our leadership team brings more than 100 years of combined experience across medtech, drug delivery, clinical medicine, and commercial strategy.
Chief Executive Officer
25+ years in medical technology, including co-founding Attwill Medical Solutions. Bill's track record of scaling MedTech companies from concept to clinical adoption positions Vector Science for aggressive, disciplined growth in the precision therapeutics market.
Chief Technology Officer
A distinguished engineer with deep expertise in drug delivery and MedTech innovation. Tom leads the technical development of Vector's core platform technologies, translating complex biomedical science into manufacturable, clinically viable devices.
Chief Medical Officer
Board-certified anesthesiologist with deep clinical expertise in perioperative care and localized intervention. Dr. Worthington provides critical clinical perspective to product development, ensuring Vector's platforms meet the practical demands of real-world patient care and regulatory standards.
Chief Commercial Officer
A seasoned commercial strategist for life sciences with a proven history of launching medical products and building partnerships across health systems, payers, and distributors. Barry drives Vector's go-to-market strategy and revenue growth initiatives.
Director, Engineering & Design
University of Michigan-trained biomedical engineer specializing in medical device design and engineering. Tabitha leads the physical development of Vector's biomechanical platforms, ensuring they meet the highest standards of efficacy, safety, and manufacturability.
Chief Financial Officer · CPA
35+ years of financial leadership as CFO and Corporate Secretary across public and private companies, including senior roles at Borealis Capital Corporation and OMERS Realty Corporation. A Chartered Public Accountant (CPA) and founder of Keshill Consulting Associates, Stephen provides the public-markets governance and financial discipline behind Vector's TSXV listing and growth strategy.
Chairman of the Board
Former U.S. Secretary of Health and Human Services and four-term Governor of Wisconsin. Tommy brings unparalleled policy experience and healthcare leadership to Vector Science, having shaped national healthcare strategy and public health initiatives at the highest level.
Board Member
President, Director and Co-Founder of HEALWELL AI (TSX:AIDX) — a world-leading healthcare artificial intelligence company focused on preventative care. With over 15 years of specialized clinical and healthcare technology experience, Dr. Dobranowski has successfully led multiple teams in the development and execution of innovative AI technology solutions to complex healthcare problems.
Board Member
A self-employed businessperson with over 22 years of capital market experience. Mr. Kelly has acted as a director and/or chief financial officer of public companies listed on the TSX.V or CSE, including Dryden Gold Corp., South Pacific Metals Corp., Mako Mining Corp., Ely Gold Royalties Corp., and Windfall Geotek Inc. He holds a Bachelor of Commerce from Royal Roads University and currently serves as Chief Executive Officer and a director of OSA.
Chief Executive Officer
25+ years in medical technology, including co-founding Attwill Medical Solutions. Bill's track record of scaling MedTech companies from concept to clinical adoption positions Vector Science for aggressive, disciplined growth in the precision therapeutics market.
Chief Commercial Officer
A seasoned commercial strategist for life sciences with a proven history of launching medical products and building partnerships across health systems, payers, and distributors. Barry drives Vector's go-to-market strategy and revenue growth initiatives.
Strategic Advisor - Capital Markets
President of Cor Capital Inc., a capital markets advisory firm specializing in capital structure, corporate development, financing, and the execution of mergers, acquisitions, and strategic transactions. Successfully led Vector Science & Therapeutics' going-public transaction by reverse takeover and listing on the TSX Venture Exchange. Former Bay Street executive with roles at J.P. Morgan, RBC Dominion Securities, and Griffiths McBurney & Partners. Former Chief Executive Officer of a leading Canadian hedge fund. Formerly a professional tennis player.
Strategic Advisor - Capital Markets & Digital Assets
CEO, entrepreneur, and financier with deep expertise across capital markets, natural resources, and emerging digital asset ecosystems. Proven track record of raising over $2 billion across public and private markets. Former Bay Street executive and associate hedge fund manager. Instrumental in the sale of Cayden Resources to Agnico Eagle. Former CEO and Head of Capital Markets at DeFi Technologies. Actively focused on the convergence of traditional finance, digital assets, and real-world asset tokenization, with a parallel emphasis on health, longevity, and performance optimization.
We're always looking for exceptional people who are passionate about improving patient lives through technology and science.
Get In Touch